<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.6957</article-id>
<article-id pub-id-type="publisher-id">mmr-16-03-3673</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MDG-1 inhibits H<sub>2</sub>O<sub>2</sub>-induced apoptosis and inflammation in human umbilical vein endothelial cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Luo-Cheng</given-names></name>
<xref rid="af1-mmr-16-03-3673" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhi-Wei</given-names></name>
<xref rid="af1-mmr-16-03-3673" ref-type="aff"/>
<xref rid="c1-mmr-16-03-3673" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Xiao-Ping</given-names></name>
<xref rid="af1-mmr-16-03-3673" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Zhi-Yong</given-names></name>
<xref rid="af1-mmr-16-03-3673" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Zhi-Peng</given-names></name>
<xref rid="af1-mmr-16-03-3673" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Ruan</surname><given-names>Yong-Le</given-names></name>
<xref rid="af1-mmr-16-03-3673" ref-type="aff"/></contrib>
</contrib-group>
<aff id="af1-mmr-16-03-3673">Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-16-03-3673"><italic>Correspondence to</italic>: Professor Zhi-Wei Wang, Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuhan, Hubei 430060, P.R. China, E-mail: <email>wangzhiwei@whu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>03</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>12</day><month>07</month><year>2017</year></pub-date>
<volume>16</volume>
<issue>3</issue>
<fpage>3673</fpage>
<lpage>3679</lpage>
<history>
<date date-type="received"><day>01</day><month>06</month><year>2016</year></date>
<date date-type="accepted"><day>05</day><month>05</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>MDG-1, a water-soluble polysaccharide extracted from <italic>Ophiopogon japonicus</italic>, has been reported to serve a role in antimyocardial ischemia by protecting cardiomyocytes from hypoxia/reoxygenation-induced damage. However, it remains unknown whether MDG-1 protects human umbilical vein endothelial cells (HUVECs) against oxidative stress-induced damage. In the present study, HUVECs were treated with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) to establish an oxidative stress-induced cell injury model. Treatment of HUVECs with different concentrations of H<sub>2</sub>O<sub>2</sub> significantly attenuated cell viability and increased cell apoptosis in a time and dose-dependent manner. Pretreatment with MDG-1 markedly reduced H<sub>2</sub>O<sub>2</sub>-induced cell death, ROS generation and inflammatory factor secretion. In addition, pretreatment with MDG-1 decreased the expression levels of proapoptotic proteins BCL2 associated X (Bax) and caspase-3, while it increased the expression levels of the antiapoptotic protein BCL2 apoptosis regulator (Bcl-2), compared with H<sub>2</sub>O<sub>2</sub> treatment alone. Taken together, the present data suggest that MDG-1 protected HUVECs against H<sub>2</sub>O<sub>2</sub>-induced apoptosis and inflammation through inhibition of Bax/Bcl-2 protein ratio, caspase-3 expression, and inflammatory factor secretion. This study provides a potential application for MDG-1 in the treatment of cardiovascular disease.</p>
</abstract>
<kwd-group>
<kwd>hydrogen peroxide</kwd>
<kwd>MDG-1</kwd>
<kwd>apoptosis</kwd>
<kwd>inflammation</kwd>
<kwd>human umbilical vein endothelial cells</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Oxidative stress is a key factor in the development of cardiovascular disease (<xref rid="b1-mmr-16-03-3673" ref-type="bibr">1</xref>). A growing body of evidence indicates the close correlation between oxidative stress and the abnormalities in endothelial function. Increased oxidative stress is a major cause of endothelial dysfunction by prolonging cell proliferation (<xref rid="b2-mmr-16-03-3673" ref-type="bibr">2</xref>), disturbing cell cycle (<xref rid="b3-mmr-16-03-3673" ref-type="bibr">3</xref>), increasing the production of reactive oxygen species (ROS) (<xref rid="b2-mmr-16-03-3673" ref-type="bibr">2</xref>), promoting inflammatory responses (<xref rid="b4-mmr-16-03-3673" ref-type="bibr">4</xref>), and activating various intracellular signal transduction pathways (<xref rid="b5-mmr-16-03-3673" ref-type="bibr">5</xref>). Furthermore, systemic and vascular ROS generation modulates inflammatory responses that contribute to microvascular and macrovascular damage (<xref rid="b6-mmr-16-03-3673" ref-type="bibr">6</xref>). Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), one of the ROS, activates protein tyrosine kinases, resulting in stimulation of downstream signaling events that regulate gene expression and in subsequent modification of cardiovascular cells.</p>
<p><italic>Ophiopogon japonicus</italic> is a plant, used in traditional Chinese medicine, and widely distributed in Southeast Asia (<xref rid="b7-mmr-16-03-3673" ref-type="bibr">7</xref>). Previous studies have revealed that <italic>O. japonicus</italic> exhibitsanti-inflammatory properties and beneficial cardiovascular effects, including anti-ischemia and anti-arrhythmic effects, inhibiting platelet aggregation, protecting endothelium from apoptosis, and improving microcirculation (<xref rid="b8-mmr-16-03-3673" ref-type="bibr">8</xref>,<xref rid="b9-mmr-16-03-3673" ref-type="bibr">9</xref>). MDG-1, a water-soluble polysaccharide extracted from <italic>O. japonicus</italic>, has been reported to protect cardiomyocytes from hypoxia/reoxygenation-induced damage (<xref rid="b10-mmr-16-03-3673" ref-type="bibr">10</xref>). In addition, MDG-1 presents remarkable anti-ischemic activity and protects cardiomyocytes and human microvascular endothelial cells (HMEC-1) from ischemia-induced cell damage through the sphingosine-1-phosphate/basic fibroblast growth factor/Akt/extracellular signal-regulated kinase (ERK)/endothelial nitric oxide synthase signaling pathway (<xref rid="b11-mmr-16-03-3673" ref-type="bibr">11</xref>).</p>
<p>Human umbilical vein endothelial cells (HUVECs) are the most widely used cell line to study the mechanisms of cardiovascular diseases. Pyruvate protects HUVECs from H<sub>2</sub>O<sub>2</sub>-induced dysfunction and improves survival following oxidative stress via blocking the mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-&#x03BA;B pathways (<xref rid="b12-mmr-16-03-3673" ref-type="bibr">12</xref>). Resveratrol protects HUVECs from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and senescence via sirtuin1 activation (<xref rid="b13-mmr-16-03-3673" ref-type="bibr">13</xref>). However, although multiple biological functions of MDG-1 have been identified to date, the potential effect of MDG-1 to the H<sub>2</sub>O<sub>2</sub>-induced endothelial injury has not been explored.</p>
<p>The specific aim of the present study was to evaluate the potential protective effect of MDG-1 in HUVECs under oxidative stress. H<sub>2</sub>O<sub>2</sub> was used to induce oxidative stress in HUVECs and to explore the effect of MDG-1 on the endothelium following oxidative stress. The present findings demonstrated that MDG-1 protected HUVECs against H<sub>2</sub>O<sub>2</sub>-induced apoptosis and inflammation, by inhibiting capspase-3 and BCL2 associated X (Bax)/BCL2 apoptosis regulator (Bcl-2) ratio expression, as well as inhibiting the secretion of inflammatory factors.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cultivation of HUVECs</title>
<p>HUVECs were purchased from the American Type Culture Collection (Manassas, VA, USA). HUVECs were cultured in Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10&#x0025; fetal bovine serum (FBS; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin and 100 &#x00B5;g/ml streptomycin. Cultures were maintained in a 37&#x00B0;C incubator under a humidified atmosphere of 5&#x0025; CO<sub>2</sub>/95&#x0025; air.</p>
</sec>
<sec>
<title>H<sub>2</sub>O<sub>2</sub>-induced HUVECs injury</title>
<p>Cultured HUVECs were pre-incubated with MDG-1 (5, 10 or 50 mM; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 12, 24 and 48 h prior to H<sub>2</sub>O<sub>2</sub> treatment (100, 300 or 500 &#x00B5;M). Following the indicated time, the medium was removed, and the cells were subjected to the subsequent experiments.</p>
</sec>
<sec>
<title>Cell viability assay</title>
<p>The Cell Counting Kit-8 (CCK-8; Dojindo Molecular technologies, Inc., Rockville, MD, USA) was used to assess cell viability in HUVECs. In brief, HUVECs in the logarithmic growth-phase were collected, and 5&#x00D7;10<sup>4</sup> cells/well were dispensed into 96-well culture plates with 100 &#x00B5;l culture medium. After 24 h of culture, different concentrations of MDG-1 (5, 10 or 50 mM) were added to each well prior to H<sub>2</sub>O<sub>2</sub> treatment (100, 300 or 500 &#x00B5;M). Each of the concentrations above was regarded as one treatment group. Culture plates were then incubated for 4, 6 and 12 h, and cell viability was evaluated by CCK-8, following the manufacturer&#x0027;s instructions. Absorbance was measured at 450 nm using a microplate reader (Molecular Devices, LLC, Sunnyvale, CA, USA). The optical density of indicated groups was used as a surrogate measurement for cell viability.</p>
</sec>
<sec>
<title>Apoptosis assay</title>
<p>HUVECs were treated with different concentrations of MDG-1 (5, 10 or 50 mM) prior to H<sub>2</sub>O<sub>2</sub> treatment (100, 300 or 500 &#x00B5;M) for 12 h. Cell apoptosis was then analyzed using the Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis kit (BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturer&#x0027;s protocol. In brief, HUVECs following treatment were washed three times with PBS, trypsinized, centrifuged (400 &#x00D7; g at room temperature) for 10 min, and resuspended to a final concentration of 5&#x00D7;10<sup>4</sup> cells/ml in binding buffer containing Annexin V-FITC and PI. Apoptotic cells were then analyzed using a BD Accuri C6 flow cytometer equipped with BD Accuri C6 software (version 1.0.264) (both from BD Biosciences).</p>
</sec>
<sec>
<title>Detection of ROS</title>
<p>HUVECs (3&#x00D7;10<sup>3</sup> cells/well) were cultured on a slide in DMEM and the indicated treatments were performed. Following treatment, the cells were washed three times with PBS, trypsinized, centrifuged (400 &#x00D7; g at room temperature) for 10 min and resuspended to a final concentration of 5&#x00D7;10<sup>4</sup> cells/ml. The dihydroethidium (DHE; 50 &#x00B5;M; Beyotime Institute of Biotechnology) probe was then added to the cells at 37&#x00B0;C for 30 min, following which the cells were analyzed by flow cytometry (BD Biosciences).</p>
</sec>
<sec>
<title>ELISA</title>
<p>HUVECs (5&#x00D7;10<sup>4</sup> cells/well) were seeded in 6-well culture plates and the indicated treatments were performed. The concentration of each secreted inflammatory factor in the cell supernatant was measured by ELISA, according to the manufacturer&#x0027;s protocol. ELISA kits were purchased as following: Human tumor necrosis factor (TNF-&#x03B1;; 070133h; Shanghai WuHao Trading Co., Ltd., Shanghai, China); human interleukin 1&#x03B2; (IL-1&#x03B2;; DL-IL1b-Hu; Wuxi DonglinSci &#x0026; Tech Development Co., Ltd., Wuxi, China); human IL-6 (ab46042; Abcam, Cambridge, MA, USA); human cyclooxygenase-2 (Cox-2; ESK5229-48T; Sangon Biotech Co., Ltd., Shanghai, China). ELISA kits were used according to the manufacturer&#x0027;s protocol.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>HUVECs were harvested, washed twice with PBS, and lyzed with radio immuno precipitation assay buffer (Beyotime Institute of Biotechnology) with freshly added 0.01&#x0025; protease inhibitor cocktail (Sigma-Aldrich; Merck KGaA) on ice for 30 min. Cell lysates were centrifuged at 1,000 &#x00D7; g for 10 min at 4&#x00B0;C. The supernatant (20&#x2013;30 &#x00B5;g of protein) was separated on 10&#x0025; SDS-PAGE and transferred electrophoretically to a polyvinylidene fluoride membrane (EMD Millipore, Billerica, MA, USA). The blots were blocked with 5&#x0025; skim milk overnight at 4&#x00B0;C, followed by incubation with primary antibodies overnight at 4&#x00B0;C. Rabbit polyclonal antibodies against Bcl-2 (cat. no. sc-492; 1:150) and Bax (cat. no. sc-493; 1:100) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). A rabbit polyclonal antibody against caspase-3 (cat. no. ab2302; 1:500) was purchased from Abcam. A rabbit monoclonal antibody against GAPDH (cat. no. 5174; 1:1,500) was purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Blots were then incubated with goat anti-rabbit secondary antibody (Beyotime Institute of Biotechnology) for 1 h at 37&#x00B0;C and visualized using enhanced chemiluminescence reagents (EMD Millipore). Quantity One 4.62 software (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to quantitatively analyze protein expression levels.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data were expressed as the mean &#x00B1; standard deviation of triplicate experiments. One-way analysis of variance, followed by Tukey&#x0027;s post hoc test, was used to analyze the significance of differences between groups with SPSS 19.0 (IBM Corp., Armonk, NY, USA). P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>H<sub>2</sub>O<sub>2</sub> induces cell death and apoptosis in HUVECs</title>
<p>To identify whether H<sub>2</sub>O<sub>2</sub> may cause cytotoxicity <italic>in vitro</italic>, the effect of H<sub>2</sub>O<sub>2</sub> on HUVEC viability was determined using the CCK-8 assay. HUVECs were treated with H<sub>2</sub>O<sub>2</sub> at concentrations of 100, 300 or 500 &#x00B5;M, and exhibited significantly decreased cell viability in a dose-dependent manner at 6 and 12 h (<xref rid="f1-mmr-16-03-3673" ref-type="fig">Fig. 1A</xref>). A flow cytometry assay was then used in order to assess the effect of H<sub>2</sub>O<sub>2</sub> on HUVEC apoptosis. HUVECs were treated with increasing concentrations of H<sub>2</sub>O<sub>2</sub> for 12 h and exhibited a significant dose-dependent increase in the &#x0025; of apoptotic cells over total, compared with untreated cells (<xref rid="f1-mmr-16-03-3673" ref-type="fig">Fig. 1B and C</xref>).</p>
</sec>
<sec>
<title>MDG-1 protects from H<sub>2</sub>O<sub>2</sub>-induced cell death and apoptosis in HUVECs</title>
<p>To investigate the effect of MDG-1 on H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity, HUVECs were pretreated with MDG-1 at different concentrations prior to exposure to 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. As presented in <xref rid="f2-mmr-16-03-3673" ref-type="fig">Fig. 2A</xref>, pretreatment of HUVECs with 5, 10 or 50 &#x00B5;M MDG-1 for 12, 24 or 48 h significantly increased cell viability in a dose-dependent manner, compared with cells treated with H<sub>2</sub>O<sub>2</sub> alone. In addition, pretreatment of HUVECs with MDG-1 at concentrations of 5, 10 or 50 mM for 24 h significantly decreased cell apoptosis in a dose-dependent manner, compared with cells treated with H<sub>2</sub>O<sub>2</sub> alone (<xref rid="f2-mmr-16-03-3673" ref-type="fig">Fig. 2B and C</xref>). These results indicate that MDG-1 pretreatment protected HUVECs against H<sub>2</sub>O<sub>2</sub>-induced toxicity.</p>
</sec>
<sec>
<title>MDG-1 inhibits H<sub>2</sub>O<sub>2</sub>-induced ROS generation in HUVECs</title>
<p>To elucidate the possible mechanisms by which MDG-1 prevented H<sub>2</sub>O<sub>2</sub>-induced HUVEC apoptosis, ROS generation was measured in HUVECs that were treated with H<sub>2</sub>O<sub>2</sub> and/or MDG-1. Exposure of HUVECs to 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h significantly enhanced ROS generation compared with untreated cells (<xref rid="f3-mmr-16-03-3673" ref-type="fig">Fig. 3</xref>). However, pretreatment with MDG-1 for 24 h (at concentrations of 5, 10 or 50 mM) significantly attenuated the H<sub>2</sub>O<sub>2</sub>-induced increase in ROS generation in a dose-dependent manner (<xref rid="f3-mmr-16-03-3673" ref-type="fig">Fig. 3</xref>). These findings demonstrated that the protective function of MDG-1 on HUVEC H<sub>2</sub>O<sub>2</sub>-induced toxicity may be associated through its antioxidant effect.</p>
</sec>
<sec>
<title>MDG-1 inhibits the H<sub>2</sub>O<sub>2</sub>-induced secretion of inflammatory factors in HUVECs</title>
<p>To determine the effect of MDG-1 in the inflammatory response of endothelial cells, secretion of the inflammatory factors TNF-&#x03B1;, IL-1&#x03B2;, IL-6 and Cox-2 was measured by ELISA in HUVECs that were treated with H<sub>2</sub>O<sub>2</sub> and/or MDG-1. The concentration of TNF-&#x03B1;, IL-1&#x03B2;, IL-6 and Cox-2 was significantly increased in H<sub>2</sub>O<sub>2</sub>-induced HUVECs, compared with untreated cells (<xref rid="f4-mmr-16-03-3673" ref-type="fig">Fig. 4</xref>). However, pretreatment with MDG-1 for 24 h resulted in a significant and dose-dependent decrease in TNF-&#x03B1;, IL-1&#x03B2;, IL-6 and Cox-2 secretion, compared with cells induced with H<sub>2</sub>O<sub>2</sub> alone (<xref rid="f4-mmr-16-03-3673" ref-type="fig">Fig. 4</xref>). These results indicated that MDG-1 pretreatment protected against H<sub>2</sub>O<sub>2</sub>-induced inflammatory responses in HUVECs.</p>
</sec>
<sec>
<title>Effect of MDG-1 on expression of apoptosis-related proteins</title>
<p>Western blot analysis was performed to detect the protein expression levels of Bax, Bcl-2 and caspase-3 in HUVECs treated with 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. H<sub>2</sub>O<sub>2</sub> treatment decreased the expression of the antiapoptotic protein Bcl-2, while it increased the expression of the proapoptotic proteins caspase-3 and Bax, compared with untreated cells (<xref rid="f5-mmr-16-03-3673" ref-type="fig">Fig. 5</xref>). Notably, MDG-1 pretreatment at concentrations of 5, 10 and 50 mM markedly reversed the effects induced by H<sub>2</sub>O<sub>2</sub> treatment on apoptosis-related protein expression, compared with cells treated with H<sub>2</sub>O<sub>2</sub> alone (<xref rid="f5-mmr-16-03-3673" ref-type="fig">Fig. 5</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Hypoxia-induced injury occurs in many diseases, including sickle cell disease (<xref rid="b14-mmr-16-03-3673" ref-type="bibr">14</xref>), cardiovascular disease (<xref rid="b15-mmr-16-03-3673" ref-type="bibr">15</xref>) and cerebrovascular disease (<xref rid="b16-mmr-16-03-3673" ref-type="bibr">16</xref>). Oxidative stress and increased inflammatory response are two key risk factors for these diseases. MDG-1, a drug extracted from <italic>O. japonicus</italic>, exerts various effects <italic>in vivo</italic>, including anti-ischemic properties (<xref rid="b17-mmr-16-03-3673" ref-type="bibr">17</xref>), cytoprotective and proangiogenic effects (<xref rid="b11-mmr-16-03-3673" ref-type="bibr">11</xref>). Therefore, the present study tested the hypothesis that MDG-1 may confer protective effects against H<sub>2</sub>O<sub>2</sub>-induced vascular injuries.</p>
<p>To investigate whether MDG-1 mayprotect HUVECs against H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity, HUVECs were pretreated with MDG-1 at concentrations 5&#x2013;50 mM for 24 h prior to exposure to 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. Notably, the results demonstrated that pretreatment with MDG-1 significantly enhanced HUVEC viability and attenuated HUVEC apoptosis induced by H<sub>2</sub>O<sub>2</sub>. The present results also indicated that the protective effects of MDG-1 were time and dose-dependent. The anticytotoxic and antiapoptotic effect of MDG-1 has also been previously reported in high-fat diet-induced obese C57BL/6 mice (<xref rid="b18-mmr-16-03-3673" ref-type="bibr">18</xref>) and ischemia-induced HMEC-1 cells (<xref rid="b11-mmr-16-03-3673" ref-type="bibr">11</xref>).</p>
<p>Another important finding of the present study was that MDG-1 inhibited oxidative stress induced by H<sub>2</sub>O<sub>2</sub> in HUVECs. Treatment with H<sub>2</sub>O<sub>2</sub> elicited a marked increase in ROS generation in HUVECs and this increased ROS production was significantly abrogated by pretreatment with MDG-1. The oxidative stress response may be a potential mechanism by which MDG-1 affects the viability of HUVECs, as it has been recently recognized as a mediator of cell apoptosis. Scavenging of intracellular ROS, such as the hydroxyl radical, or increasing the intracellular levels of reduced glutathione with membrane-permeable antioxidants, significantly blocks apoptosis in endothelial cells (<xref rid="b19-mmr-16-03-3673" ref-type="bibr">19</xref>). Intracellular ROS has been demonstrated to function as a second messenger activating a set of MAPK family members, including ERK1/2 (<xref rid="b20-mmr-16-03-3673" ref-type="bibr">20</xref>), c-Jun N-terminal kinase (<xref rid="b21-mmr-16-03-3673" ref-type="bibr">21</xref>) and p38 MAPK (<xref rid="b22-mmr-16-03-3673" ref-type="bibr">22</xref>). Further studies will be required to elucidate other pathways mediating the inhibition of ROS generation by MDG-1, such as the phosphoinositide 3-kinase/Akt pathway (<xref rid="b23-mmr-16-03-3673" ref-type="bibr">23</xref>).</p>
<p>The inflammatory response is an important contributing factor in H<sub>2</sub>O<sub>2</sub>-induced injury. Several inflammatory cytokines are induced by H<sub>2</sub>O<sub>2</sub> in endothelial cells (<xref rid="b24-mmr-16-03-3673" ref-type="bibr">24</xref>). Ophiopogonin D inhibits H<sub>2</sub>O<sub>2</sub>-induced secretion of inflammatory factors, such as TNF-&#x03B1; and IL-6, in HUVECs (<xref rid="b25-mmr-16-03-3673" ref-type="bibr">25</xref>). Therefore, H<sub>2</sub>O<sub>2</sub> is a powerful proinflammatory mediator in endothelial cells. In the present study, besides cytotoxicity and oxidative stress, H<sub>2</sub>O<sub>2</sub> treatment also affected the inflammatory response in HUVECs, as evidenced by an increase in the secretion of TNF-&#x03B1;, IL-1&#x03B2;, IL-6 and Cox-2. Of note, MDG-1 pretreatment significantly attenuated this H<sub>2</sub>O<sub>2</sub>-stimulated increase in TNF-&#x03B1;, IL-1&#x03B2;, IL-6 and Cox-2 secretion in HUVECs, suggesting that MDG-1 protected HUVECs against H<sub>2</sub>O<sub>2</sub>-induced inflammatory response. Cox-2 is a potent proinflammatory mediator that promotes the production of multiple inflammatory factors (<xref rid="b26-mmr-16-03-3673" ref-type="bibr">26</xref>). The Huang Qi herb, which is frequently used in traditional Chinese medicine, has been reported to reduce ischemia/reperfusion-induced injury partly by inhibition of Cox-2 (<xref rid="b27-mmr-16-03-3673" ref-type="bibr">27</xref>). In addition, Cox-2 inhibition by NS-398 can confer anti-inflammatory effects, decreasing IL-6 secretion and increasing IL-10 secretion in a liver damage rat model (<xref rid="b28-mmr-16-03-3673" ref-type="bibr">28</xref>). These data suggest that IL-6 and Cox-2 are proinflammatory factors. However, IL-6 confers cytoprotective effects by diminishing oxidant-mediated endothelial cell injury, mediated partly by a signal transducer and activator of transcription 3 and MAPK kinase 1 signaling (<xref rid="b29-mmr-16-03-3673" ref-type="bibr">29</xref>). These results imply that different cell type, disease model and experimental conditions may affect the precise function of IL-6. Thus, the biological effects of IL-6 on H<sub>2</sub>O<sub>2</sub>-induced inflammation require further research <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
<p>Pretreatment of HUVECs with catalpol increases expression of Bcl-2, decreases expression of Bax, induces Akt activation and BCL2 associated agonist of cell death (Bad) phosphorylation, and ultimately results in reduced H<sub>2</sub>O<sub>2</sub>-induced apoptosis (<xref rid="b30-mmr-16-03-3673" ref-type="bibr">30</xref>). Among the Bcl-2 family, several members, such as Bcl-2 and Bcl-extra large induce cell survival, while other members, such as Bad and Bax, promote cell death (<xref rid="b31-mmr-16-03-3673" ref-type="bibr">31</xref>). Furthermore, it has been demonstrated that members of the Bcl-2 family, which are located on the mitochondrial membrane, can alter mitochondrial membrane permeability and trigger apoptosis (<xref rid="b32-mmr-16-03-3673" ref-type="bibr">32</xref>). H<sub>2</sub>O<sub>2</sub> has been reported to induce cell death in U937 myeloid cells by decreasing the Bcl-2/Bax ratio (<xref rid="b33-mmr-16-03-3673" ref-type="bibr">33</xref>). H<sub>2</sub>O<sub>2</sub> has also been reported to induce apoptosis in PC12 rat adrenal pheochromocytoma cells via activation of caspase-3 (<xref rid="b34-mmr-16-03-3673" ref-type="bibr">34</xref>). In the present study, H<sub>2</sub>O<sub>2</sub> treatment decreased the expression of Bcl-2, while it increased the expression of the proapoptotic proteins caspase-3 and Bax in HUVECs, compared with untreated cells. Notably, MDG-1 pretreatment markedly reversed these H<sub>2</sub>O<sub>2</sub>-induced effects.</p>
<p>In conclusion, the present results indicated that MDG-1 may be a potential candidate for preventing oxidative stress-induced damage to endothelial cells. Further studies are required to fully elucidate the potential utility of MDG-1 in protection against cardiovascular dysfunction.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by the National Natural Foundation of China (grant no. 81501376) and the Fundamental Research Funds for the Central Universities (grant no. 2042017kf0111).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-16-03-3673"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heitzer</surname><given-names>T</given-names></name><name><surname>Schlinzig</surname><given-names>T</given-names></name><name><surname>Krohn</surname><given-names>K</given-names></name><name><surname>Meinertz</surname><given-names>T</given-names></name><name><surname>M&#x00FC;nzel</surname><given-names>T</given-names></name></person-group><article-title>Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease</article-title><source>Circulation</source><volume>104</volume><fpage>2673</fpage><lpage>2678</lpage><year>2001</year><pub-id pub-id-type="doi">10.1161/hc4601.099485</pub-id><pub-id pub-id-type="pmid">11723017</pub-id></element-citation></ref>
<ref id="b2-mmr-16-03-3673"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wold</surname><given-names>LE</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name></person-group><article-title>Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: Role of ETB receptor, NADPH oxidase and caveolin-1</article-title><source>Brit J Pharmacol</source><volume>145</volume><fpage>323</fpage><lpage>333</lpage><year>2005</year><pub-id pub-id-type="doi">10.1038/sj.bjp.0706193</pub-id></element-citation></ref>
<ref id="b3-mmr-16-03-3673"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assmus</surname><given-names>B</given-names></name><name><surname>Urbich</surname><given-names>C</given-names></name><name><surname>Aicher</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>WK</given-names></name><name><surname>Haendeler</surname><given-names>J</given-names></name><name><surname>R&#x00F6;ssig</surname><given-names>L</given-names></name><name><surname>Spyridopoulos</surname><given-names>I</given-names></name><name><surname>Zeiher</surname><given-names>AM</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name></person-group><article-title>HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes</article-title><source>Circ Res</source><volume>92</volume><fpage>1049</fpage><lpage>1055</lpage><year>2003</year><pub-id pub-id-type="doi">10.1161/01.RES.0000070067.64040.7C</pub-id><pub-id pub-id-type="pmid">12676819</pub-id></element-citation></ref>
<ref id="b4-mmr-16-03-3673"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapp</surname><given-names>BR</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Kharbanda</surname><given-names>RK</given-names></name><name><surname>Mohamed-Ali</surname><given-names>V</given-names></name><name><surname>Stephens</surname><given-names>JW</given-names></name><name><surname>Vallance</surname><given-names>P</given-names></name><name><surname>MacAllister</surname><given-names>RJ</given-names></name></person-group><article-title>Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress</article-title><source>Cardiovasc Res</source><volume>64</volume><fpage>172</fpage><lpage>178</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.06.020</pub-id><pub-id pub-id-type="pmid">15364625</pub-id></element-citation></ref>
<ref id="b5-mmr-16-03-3673"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DI</given-names></name><name><surname>Griendling</surname><given-names>KK</given-names></name></person-group><article-title>Regulation of signal transduction by reactive oxygen species in the cardiovascular system</article-title><source>Circ Res</source><volume>116</volume><fpage>531</fpage><lpage>549</lpage><year>2015</year><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.303584</pub-id><pub-id pub-id-type="pmid">25634975</pub-id><pub-id pub-id-type="pmcid">4392388</pub-id></element-citation></ref>
<ref id="b6-mmr-16-03-3673"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Motz</surname><given-names>E</given-names></name></person-group><article-title>Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited</article-title><source>Arterioscl Throm Vas Biol</source><volume>24</volume><fpage>816</fpage><lpage>823</lpage><year>2004</year><pub-id pub-id-type="doi">10.1161/01.ATV.0000122852.22604.78</pub-id></element-citation></ref>
<ref id="b7-mmr-16-03-3673"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>CL</given-names></name><name><surname>Kang</surname><given-names>ZY</given-names></name><name><surname>Lin</surname><given-names>CR</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>JX</given-names></name><name><surname>Tu</surname><given-names>PF</given-names></name></person-group><article-title>Two new homoisoflavonoids from the fibrous roots of <italic>Ophiopogon japonicus</italic> (Thunb.) Ker-Gawl</article-title><source>J Asian Nat Prod Res</source><volume>11</volume><fpage>876</fpage><lpage>879</lpage><year>2009</year><pub-id pub-id-type="doi">10.1080/10286020903093161</pub-id><pub-id pub-id-type="pmid">20183249</pub-id></element-citation></ref>
<ref id="b8-mmr-16-03-3673"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kou</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name></person-group><article-title>Anti-inflammatory activities of aqueous extract from Radix <italic>Ophiopogon japonicus</italic> and its two constituents</article-title><source>Biol Pharma Bull</source><volume>28</volume><fpage>1234</fpage><lpage>1238</lpage><year>2005</year><pub-id pub-id-type="doi">10.1248/bpb.28.1234</pub-id></element-citation></ref>
<ref id="b9-mmr-16-03-3673"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kou</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name></person-group><article-title>Antithrombotic activities of aqueous extract from Radix <italic>Ophiopogon japonicus</italic> and its two constituents</article-title><source>Biol Pharm Bull</source><volume>29</volume><fpage>1267</fpage><lpage>1270</lpage><year>2006</year><pub-id pub-id-type="doi">10.1248/bpb.29.1267</pub-id><pub-id pub-id-type="pmid">16755031</pub-id></element-citation></ref>
<ref id="b10-mmr-16-03-3673"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>DS</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>YZ</given-names></name></person-group><article-title>Influence of sulfation on anti-myocardial ischemic activity of <italic>Ophiopogon japonicus</italic> polysaccharide</article-title><source>J Asian Nat Prod Res</source><volume>11</volume><fpage>306</fpage><lpage>321</lpage><year>2009</year><pub-id pub-id-type="doi">10.1080/10286020902727363</pub-id><pub-id pub-id-type="pmid">19431010</pub-id></element-citation></ref>
<ref id="b11-mmr-16-03-3673"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>DS</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>K</given-names></name></person-group><article-title>A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart</article-title><source>Glycobiology</source><volume>20</volume><fpage>473</fpage><lpage>484</lpage><year>2010</year><pub-id pub-id-type="doi">10.1093/glycob/cwp199</pub-id><pub-id pub-id-type="pmid">20008963</pub-id></element-citation></ref>
<ref id="b12-mmr-16-03-3673"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Kang</surname><given-names>IJ</given-names></name><name><surname>B&#x00FC;nger</surname><given-names>R</given-names></name><name><surname>Kang</surname><given-names>YH</given-names></name></person-group><article-title>Enhanced survival effect of pyruvate correlates MAPK and NF-kappaB activation in hydrogen peroxide-treated human endothelial cells</article-title><source>J Appl Physiol (1985)</source><volume>96</volume><fpage>792</fpage><lpage>801</lpage><year>2004</year><pub-id pub-id-type="doi">10.1152/japplphysiol.00797.2003</pub-id></element-citation></ref>
<ref id="b13-mmr-16-03-3673"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>LK</given-names></name><name><surname>Chang</surname><given-names>YL</given-names></name><name><surname>Yung</surname><given-names>MC</given-names></name><name><surname>Hsu</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Lo</surname><given-names>WL</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Ku</surname><given-names>HH</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name></person-group><article-title>Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation</article-title><source>J Atheroscl Throm</source><volume>17</volume><fpage>970</fpage><lpage>979</lpage><year>2010</year><pub-id pub-id-type="doi">10.5551/jat.4333</pub-id></element-citation></ref>
<ref id="b14-mmr-16-03-3673"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>KA</given-names></name><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Ou</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Franciosi</surname><given-names>JP</given-names></name><name><surname>Signorino</surname><given-names>P</given-names></name><name><surname>Kaul</surname><given-names>S</given-names></name><name><surname>Ackland-Berglund</surname><given-names>C</given-names></name><name><surname>Witte</surname><given-names>K</given-names></name><name><surname>Holzhauer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hypoxia-induced acute lung injury in murine models of sickle cell disease</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>286</volume><fpage>L705</fpage><lpage>L714</lpage><year>2004</year><pub-id pub-id-type="doi">10.1152/ajplung.00288.2002</pub-id><pub-id pub-id-type="pmid">12972407</pub-id></element-citation></ref>
<ref id="b15-mmr-16-03-3673"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>H</given-names></name><name><surname>Morishita</surname><given-names>R</given-names></name><name><surname>Nata</surname><given-names>T</given-names></name><name><surname>Aoki</surname><given-names>M</given-names></name><name><surname>Nakagami</surname><given-names>H</given-names></name><name><surname>Taniyama</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Higaki</surname><given-names>J</given-names></name><name><surname>Yasufumi</surname><given-names>K</given-names></name><name><surname>Ogihara</surname><given-names>T</given-names></name></person-group><article-title>Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: In vivo evidence of the importance of NF-kappaB in endothelial cell regulation</article-title><source>Circ Res</source><volume>86</volume><fpage>974</fpage><lpage>981</lpage><year>2000</year><pub-id pub-id-type="doi">10.1161/01.RES.86.9.974</pub-id><pub-id pub-id-type="pmid">10807870</pub-id></element-citation></ref>
<ref id="b16-mmr-16-03-3673"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chrissobolis</surname><given-names>S</given-names></name><name><surname>Faraci</surname><given-names>FM</given-names></name></person-group><article-title>The role of oxidative stress and NADPH oxidase in cerebrovascular disease</article-title><source>Trends Mol Med</source><volume>14</volume><fpage>495</fpage><lpage>502</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.molmed.2008.09.003</pub-id><pub-id pub-id-type="pmid">18929509</pub-id><pub-id pub-id-type="pmcid">3140460</pub-id></element-citation></ref>
<ref id="b17-mmr-16-03-3673"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>Ruan</surname><given-names>KF</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name></person-group><article-title>A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression</article-title><source>Int J Biol Macromol</source><volume>50</volume><fpage>734</fpage><lpage>740</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.12.005</pub-id><pub-id pub-id-type="pmid">22197795</pub-id></element-citation></ref>
<ref id="b18-mmr-16-03-3673"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>LL</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name></person-group><article-title>MDG-1, an <italic>Ophiopogon</italic> polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice</article-title><source>Int J Biol Macromol</source><volume>81</volume><fpage>576</fpage><lpage>583</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.08.057</pub-id><pub-id pub-id-type="pmid">26321425</pub-id></element-citation></ref>
<ref id="b19-mmr-16-03-3673"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abello</surname><given-names>PA</given-names></name><name><surname>Fidler</surname><given-names>SA</given-names></name><name><surname>Bulkley</surname><given-names>GB</given-names></name><name><surname>Buchman</surname><given-names>TG</given-names></name></person-group><article-title>Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin</article-title><source>Arch Surg</source><volume>129</volume><fpage>134</fpage><lpage>141</lpage><year>1994</year><pub-id pub-id-type="doi">10.1001/archsurg.1994.01420260030003</pub-id><pub-id pub-id-type="pmid">8304825</pub-id></element-citation></ref>
<ref id="b20-mmr-16-03-3673"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>N</given-names></name><name><surname>Zmijewski</surname><given-names>JW</given-names></name><name><surname>Takabe</surname><given-names>W</given-names></name><name><surname>Umezu-Goto</surname><given-names>M</given-names></name><name><surname>Le Goffe</surname><given-names>C</given-names></name><name><surname>Sekine</surname><given-names>A</given-names></name><name><surname>Landar</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>A</given-names></name><name><surname>Aoki</surname><given-names>J</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><etal/></person-group><article-title>Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells</article-title><source>Am J Pathol</source><volume>168</volume><fpage>1737</fpage><lpage>1748</lpage><year>2006</year><pub-id pub-id-type="doi">10.2353/ajpath.2006.050648</pub-id><pub-id pub-id-type="pmid">16651638</pub-id><pub-id pub-id-type="pmcid">1606607</pub-id></element-citation></ref>
<ref id="b21-mmr-16-03-3673"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SJ</given-names></name><name><surname>Shyue</surname><given-names>SK</given-names></name><name><surname>Liu</surname><given-names>PL</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Ku</surname><given-names>HH</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name><name><surname>Tam</surname><given-names>&#x03BA;B</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name></person-group><article-title>Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways</article-title><source>J Mol Cell Cardiol</source><volume>36</volume><fpage>129</fpage><lpage>139</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.yjmcc.2003.10.011</pub-id><pub-id pub-id-type="pmid">14734055</pub-id></element-citation></ref>
<ref id="b22-mmr-16-03-3673"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usatyuk</surname><given-names>PV</given-names></name><name><surname>Vepa</surname><given-names>S</given-names></name><name><surname>Watkins</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Parinandi</surname><given-names>NL</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name></person-group><article-title>Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells</article-title><source>Antioxid Redox Sign</source><volume>5</volume><fpage>723</fpage><lpage>730</lpage><year>2003</year><pub-id pub-id-type="doi">10.1089/152308603770380025</pub-id></element-citation></ref>
<ref id="b23-mmr-16-03-3673"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>DS</given-names></name><name><surname>Ruan</surname><given-names>KF</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>MDG-1, a polysaccharide from <italic>Ophiopogon japonicus</italic> exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model</article-title><source>J Ethnopharmacol</source><volume>143</volume><fpage>347</fpage><lpage>354</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.jep.2012.06.050</pub-id><pub-id pub-id-type="pmid">22776833</pub-id></element-citation></ref>
<ref id="b24-mmr-16-03-3673"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences</article-title><source>Cardiovasc Res</source><volume>68</volume><fpage>26</fpage><lpage>36</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.cardiores.2005.06.021</pub-id><pub-id pub-id-type="pmid">16009356</pub-id></element-citation></ref>
<ref id="b25-mmr-16-03-3673"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name></person-group><article-title>Ophiopogonin D prevents H<sub>2</sub>O<sub>2</sub>-induced injury in primary human umbilical vein endothelial cells</article-title><source>J Ethnopharmacol</source><volume>128</volume><fpage>438</fpage><lpage>445</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.jep.2010.01.031</pub-id><pub-id pub-id-type="pmid">20083185</pub-id></element-citation></ref>
<ref id="b26-mmr-16-03-3673"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lan</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name></person-group><article-title>Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS/NF-&#x03BA;B/COX-2 pathway</article-title><source>PLoS One</source><volume>6</volume><fpage>e21971</fpage><year>2011</year><pub-id pub-id-type="doi">10.1371/journal.pone.0021971</pub-id><pub-id pub-id-type="pmid">21779360</pub-id><pub-id pub-id-type="pmcid">3136491</pub-id></element-citation></ref>
<ref id="b27-mmr-16-03-3673"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name></person-group><article-title>Suppression of cyclooxygenase-2 expression of skin fibroblasts by wogonin, a plant flavone from <italic>Scutellaria radix</italic></article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><volume>72</volume><fpage>59</fpage><lpage>66</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.plefa.2004.04.009</pub-id><pub-id pub-id-type="pmid">15589400</pub-id></element-citation></ref>
<ref id="b28-mmr-16-03-3673"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>B</given-names></name><name><surname>He</surname><given-names>MY</given-names></name><name><surname>Zhu</surname><given-names>XL</given-names></name><name><surname>Zhou</surname><given-names>WC</given-names></name><name><surname>Wachtel</surname><given-names>MS</given-names></name><name><surname>Frezza</surname><given-names>E</given-names></name></person-group><article-title>COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats</article-title><source>J Surg Res</source><volume>157</volume><fpage>43</fpage><lpage>47</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.jss.2008.12.020</pub-id><pub-id pub-id-type="pmid">19765729</pub-id></element-citation></ref>
<ref id="b29-mmr-16-03-3673"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname><given-names>AB</given-names></name><name><surname>Mahboubi</surname><given-names>K</given-names></name><name><surname>Knickelbein</surname><given-names>RG</given-names></name><name><surname>Mantell</surname><given-names>LL</given-names></name><name><surname>Manzo</surname><given-names>N</given-names></name><name><surname>Pober</surname><given-names>JS</given-names></name><name><surname>Elias</surname><given-names>JA</given-names></name></person-group><article-title>Interleukin-11 and interleukin-6 protect cultured human endothelial cells from H<sub>2</sub>O<sub>2</sub>-induced cell death</article-title><source>Am J Respir Cell Mol Biol</source><volume>29</volume><fpage>513</fpage><lpage>522</lpage><year>2003</year><pub-id pub-id-type="doi">10.1165/rcmb.2002-0044OC</pub-id><pub-id pub-id-type="pmid">12730073</pub-id></element-citation></ref>
<ref id="b30-mmr-16-03-3673"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name></person-group><article-title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</article-title><source>Eur J Pharmacol</source><volume>628</volume><fpage>155</fpage><lpage>163</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.11.046</pub-id><pub-id pub-id-type="pmid">19962976</pub-id></element-citation></ref>
<ref id="b31-mmr-16-03-3673"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivetti</surname><given-names>G</given-names></name><name><surname>Abbi</surname><given-names>R</given-names></name><name><surname>Quaini</surname><given-names>F</given-names></name><name><surname>Kajstura</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Nitahara</surname><given-names>JA</given-names></name><name><surname>Quaini</surname><given-names>E</given-names></name><name><surname>Di Loreto</surname><given-names>C</given-names></name><name><surname>Beltrami</surname><given-names>CA</given-names></name><name><surname>Krajewski</surname><given-names>S</given-names></name><etal/></person-group><article-title>Apoptosis in the failing human heart</article-title><source>New Engl J Med</source><volume>336</volume><fpage>1131</fpage><lpage>1141</lpage><year>1997</year><pub-id pub-id-type="doi">10.1056/NEJM199704173361603</pub-id><pub-id pub-id-type="pmid">9099657</pub-id></element-citation></ref>
<ref id="b32-mmr-16-03-3673"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XM</given-names></name><name><surname>Bratton</surname><given-names>SB</given-names></name><name><surname>Butterworth</surname><given-names>M</given-names></name><name><surname>MacFarlane</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>GM</given-names></name></person-group><article-title>Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein</article-title><source>J Biol Chem</source><volume>277</volume><fpage>11345</fpage><lpage>11351</lpage><year>2002</year><pub-id pub-id-type="doi">10.1074/jbc.M109893200</pub-id><pub-id pub-id-type="pmid">11801595</pub-id></element-citation></ref>
<ref id="b33-mmr-16-03-3673"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukamachi</surname><given-names>Y</given-names></name><name><surname>Karasaki</surname><given-names>Y</given-names></name><name><surname>Sugiura</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Yamamura</surname><given-names>K</given-names></name><name><surname>Higashi</surname><given-names>K</given-names></name></person-group><article-title>Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio</article-title><source>Biochem Biophys Res Commun</source><volume>246</volume><fpage>364</fpage><lpage>369</lpage><year>1998</year><pub-id pub-id-type="doi">10.1006/bbrc.1998.8621</pub-id><pub-id pub-id-type="pmid">9610364</pub-id></element-citation></ref>
<ref id="b34-mmr-16-03-3673"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamakawa</surname><given-names>H</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Naganawa</surname><given-names>T</given-names></name><name><surname>Banno</surname><given-names>Y</given-names></name><name><surname>Nakashima</surname><given-names>S</given-names></name><name><surname>Yoshimura</surname><given-names>S</given-names></name><name><surname>Sawada</surname><given-names>M</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Nozawa</surname><given-names>Y</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name></person-group><article-title>Activation of caspase-9 and-3 during H<sub>2</sub>O<sub>2</sub>-induced apoptosis of PC12 cells independent of ceramide formation</article-title><source>Neurol Res</source><volume>22</volume><fpage>556</fpage><lpage>564</lpage><year>2000</year><pub-id pub-id-type="doi">10.1080/01616412.2000.11740718</pub-id><pub-id pub-id-type="pmid">11045015</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-16-03-3673" position="float">
<label>Figure 1.</label>
<caption><p>H<sub>2</sub>O<sub>2</sub> induces cell death and apoptosis in HUVECs. (A) HUVECs were treated with H<sub>2</sub>O<sub>2</sub> at indicated concentrations for 4, 6 and 12 h and cell viability was evaluated using a Cell Counting Kit-8 assay. (B and C) HUVECs were treated with H<sub>2</sub>O<sub>2</sub> at indicated concentrations for 12 h and cell apoptosis was assessed by Annexin V-fluorescein isothiocyanate/propidium iodide staining and flow cytometry analysis. &#x002A;&#x002A;P&#x003C;0.01 and &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. untreated control. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; HUVECs, human umbilical vein endothelial cells.</p></caption>
<graphic xlink:href="MMR-16-03-3673-g00.tif"/>
</fig>
<fig id="f2-mmr-16-03-3673" position="float">
<label>Figure 2.</label>
<caption><p>MDG-1 protects HUVECs against H<sub>2</sub>O<sub>2</sub>-mediated cell death and apoptosis. HUVECs were pretreated with MDG-1 at indicated concentrations for 12, 24 and 48 h prior to treatment with H<sub>2</sub>O<sub>2</sub> at 300 &#x00B5;M for 12 h. (A) Cell viability was evaluated using a Cell Counting Kit-8 assay. (B and C) Cell apoptosis was assessed by Annexin V-fluorescein isothiocyanate/propidium iodide staining and flow cytometry analysis. &#x002A;&#x002A;P&#x003C;0.01 and &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. untreated control; <sup>#</sup>P&#x003C;0.05, <sup>##</sup>P&#x003C;0.01 and <sup>###</sup>P&#x003C;0.001 vs. H<sub>2</sub>O<sub>2</sub> treatment alone. HUVECs, human umbilical vein endothelial cells; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption>
<graphic xlink:href="MMR-16-03-3673-g01.tif"/>
</fig>
<fig id="f3-mmr-16-03-3673" position="float">
<label>Figure 3.</label>
<caption><p>MDG-1 reduces H<sub>2</sub>O<sub>2</sub>-mediated ROS generation in HUVECs. HUVECs were pretreated with the indicated concentrations of MDG-1 for 24 h prior to treatment with 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. Fluorescence intensity resulting from a ROS probe was measured by flow cytometry. &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. untreated control; <sup>##</sup>P&#x003C;0.01 and <sup>###</sup>P&#x003C;0.001 vs. H<sub>2</sub>O<sub>2</sub> treatment alone. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; ROS, reactive oxygen species; HUVECs, human umbilical vein endothelial cells.</p></caption>
<graphic xlink:href="MMR-16-03-3673-g02.tif"/>
</fig>
<fig id="f4-mmr-16-03-3673" position="float">
<label>Figure 4.</label>
<caption><p>MDG-1 reduces H<sub>2</sub>O<sub>2</sub>-mediated secretion of inflammatory factors in HUVECs. HUVECs were pretreated with the indicated concentrations of MDG-1 for 24 h prior to treatment with 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. The concentration of TNF-&#x03B1;, IL-1&#x03B2;, IL-6 and Cox-2 was measured in cell supernatants by ELISA. &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. untreated control; <sup>##</sup>P&#x003C;0.01 and <sup>###</sup>P&#x003C;0.001 vs. H<sub>2</sub>O<sub>2</sub> treatment alone. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; HUVECs, human umbilical vein endothelial cells; TNF, tumor necrosis factor; IL, interleukin; Cox, cyclooxygenase.</p></caption>
<graphic xlink:href="MMR-16-03-3673-g03.tif"/>
</fig>
<fig id="f5-mmr-16-03-3673" position="float">
<label>Figure 5.</label>
<caption><p>Effect of MDG-1 on expression of apoptosis-related proteins. HUVECs were pretreated with the indicated concentrations of MDG-1 for 24 h prior to treatment with 300 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. Protein expression levels of Bax, Bcl-2 and caspase-3 were measured by western blot analysis. Representative blot images and quantitative results are depicted, with GAPDH used as a normalization control. &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. untreated control; <sup>#</sup>P&#x003C;0.05, <sup>##</sup>P&#x003C;0.01 and <sup>###</sup>P&#x003C;0.001 vs. H<sub>2</sub>O<sub>2</sub> treatment alone. HUVECs, human umbilical vein endothelial cells; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; Bax, BCL2 associated X; Bcl-2, BCL2 apoptosis regulator.</p></caption>
<graphic xlink:href="MMR-16-03-3673-g04.tif"/>
</fig>
</floats-group>
</article>